DGK-Positionspapier zu medikamentenfreisetzenden Koronarstents/-scaffolds und medikamentenbeschichteten Ballonkathetern: Aus der Kommission für Klinische Kardiovaskuläre Medizin in Kooperation mit der Arbeitsgruppe Interventionelle Kardiologie (AGIK)

Translated title of the contribution: Position paper of the German Cardiac Society on drug-releasing coronary stents/scaffolds and drug-coated balloon catheters: From the Committee for Clinical Cardiovascular Medicine in cooperation with the Working Group Interventional Cardiology (AGIK)

Holger M. Nef, Ingo Ahrens, Oliver Dörr, Luise Gaede, Tommaso Gori, Felix J. Hofmann, Michael Joner, Ulf Landmesser, Helge Möllmann, Thomas Schmitz, Stephan Fichtlscherer, Jan Malte Sinning

Research output: Contribution to journalArticlepeer-review

Abstract

The continuous advancement of stent technologies since the introduction of percutaneous catheter intervention continues to pose challenges for interventional cardiologists, even after the last position paper. Selecting appropriate devices requires not only a solid understanding of current study results but also an individualized approach tailored to each patient’s specific clinical situation. Additionally, the broader use of imaging provides valuable information that enables a more personalized treatment strategy. This update of the position paper provides a comprehensive overview of the drug-coated stents, scaffolds and balloons currently available in Germany. In addition to a detailed analysis of recent studies, it particularly focuses on the clinical indications.

Translated title of the contributionPosition paper of the German Cardiac Society on drug-releasing coronary stents/scaffolds and drug-coated balloon catheters: From the Committee for Clinical Cardiovascular Medicine in cooperation with the Working Group Interventional Cardiology (AGIK)
Original languageGerman
JournalKardiologie
DOIs
StateAccepted/In press - 2025

Fingerprint

Dive into the research topics of 'Position paper of the German Cardiac Society on drug-releasing coronary stents/scaffolds and drug-coated balloon catheters: From the Committee for Clinical Cardiovascular Medicine in cooperation with the Working Group Interventional Cardiology (AGIK)'. Together they form a unique fingerprint.

Cite this